 Wall Street brokerages expect Crinetics Pharmaceuticals Inc NASDAQ:CRNX to announce earnings of 0.63 per share for the current quarter, according to Zacks. Zero analysts have made estimates for Crinetics Pharmaceuticals earnings. The lowest EPS estimate is 0.70 and the highest is 0.60. Crinetics Pharmaceuticals reported earnings of 0.37 per share during the same quarter last ... 